Trial · NCT03122860
Adverse events210
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
61 to 80 of 210
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 4 | 114 | 4 |
| other | Upper respiratory tract infection | Infections and infestations | Sham | 4 | 120 | 5 |
| other | Upper respiratory tract infection | Infections and infestations | Other | 1 | 39 | 1 |
| other | Urinary tract infection | Infections and infestations | 0.03 mg SM04690 | 1 | 106 | 1 |
| other | Urinary tract infection | Infections and infestations | 0.07 mg SM04690 | 1 | 104 | 1 |
| other | Urinary tract infection | Infections and infestations | 0.15 mg SM04690 | 1 | 106 | 1 |
| other | Urinary tract infection | Infections and infestations | 0.23 mg SM04690 | 1 | 106 | 1 |
| other | Urinary tract infection | Infections and infestations | Placebo | 1 | 114 | 1 |
| other | Urinary tract infection | Infections and infestations | Sham | 4 | 120 | 4 |
| other | Urinary tract infection | Infections and infestations | Other | 1 | 39 | 1 |
| other | Viral upper respiratory tract infection | Infections and infestations | 0.03 mg SM04690 | 2 | 106 | 2 |
| other | Viral upper respiratory tract infection | Infections and infestations | 0.07 mg SM04690 | 2 | 104 | 2 |
| other | Viral upper respiratory tract infection | Infections and infestations | 0.15 mg SM04690 | 0 | 106 | 0 |
| other | Viral upper respiratory tract infection | Infections and infestations | 0.23 mg SM04690 | 1 | 106 | 1 |
| other | Viral upper respiratory tract infection | Infections and infestations | Placebo | 3 | 114 | 3 |
| other | Viral upper respiratory tract infection | Infections and infestations | Sham | 1 | 120 | 1 |
| other | Viral upper respiratory tract infection | Infections and infestations | Other | 0 | 39 | 0 |
| other | Blood lactate dehydrogenase increased | Investigations | 0.03 mg SM04690 | 1 | 106 | 1 |
| other | Blood lactate dehydrogenase increased | Investigations | 0.07 mg SM04690 | 0 | 104 | 0 |
| other | Blood lactate dehydrogenase increased | Investigations | 0.15 mg SM04690 | 3 | 106 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03122860/events?page=4